Literature DB >> 12790016

Dry mouth: aging and oral health.

Mahvash Navazesh1.   

Abstract

Dry mouth is a common complaint among older adults, and the aging process is erroneously considered by many to be the primary cause. The subjective complaint of dry mouth (xerostomia) is not always associated with objective evidence of a reduced saliva flow rate (salivary gland hypofunction). Moreover, there are patients who have reduced saliva flow rates and are asymptomatic. Xerostomia and salivary gland hypofunction are associated with sundry oral and systemic complications and affect the quality of an individual's life. This article includes the common causes of xerostomia and salivary gland hypofunction and addresses the common complications of and routine therapeutic modalities available for these conditions in the elderly.

Entities:  

Mesh:

Year:  2002        PMID: 12790016

Source DB:  PubMed          Journal:  Compend Contin Educ Dent        ISSN: 1548-8578


  4 in total

1.  Dental prosthetic status and prosthetic needs of institutionalised elderly population in oldage homes of jabalpur city, madhya pradesh, India.

Authors:  Suryakant C Deogade; S Vinay; Sonal Naidu
Journal:  J Indian Prosthodont Soc       Date:  2012-12-09

Review 2.  Oral health in geroscience: animal models and the aging oral cavity.

Authors:  Jonathan Y An; Richard Darveau; Matt Kaeberlein
Journal:  Geroscience       Date:  2017-12-27       Impact factor: 7.713

3.  Management of xerostomia in older patients : a randomised controlled trial evaluating the efficacy of a new oral lubricant solution.

Authors:  Stéphane Mouly; Michel Salom; Yves Tillet; Anne-Claude Coudert; Frantz Oberli; Philip M Preshaw; Stéphane Desjonquères; Jean-François Bergmann
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

4.  Significant variation in salivation by short-term suggestive intervention: a randomized controlled cross-over clinical study.

Authors:  Maximilian Satzl; Albrecht Schmierer; Florian Zeman; Gottfried Schmalz; Thomas Loew
Journal:  Head Face Med       Date:  2014-11-27       Impact factor: 2.151

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.